|
CN105030710A
|
|
Arbidol tablet
|
|
CN104959096A
|
|
Photoreaction equipment
|
|
CN104959095A
|
|
Photoreaction device
|
|
CN104923142A
|
|
System used for preparing compound
|
|
CN104984702A
|
|
Photoreaction system
|
|
CN104983706A
|
|
Sodium prasterone sulfate sustained-release tablet and preparation process thereof
|
|
CN105085483A
|
|
Kinase inhibitor and application thereof
|
|
CN104983696A
|
|
Sodium prasterone sulfate dispersible tablet and preparation method thereof
|
|
CN104983705A
|
|
Sodium prasterone sulfate sustained-release tablet and preparation method thereof
|
|
CN104987324A
|
|
Pyrimidine derivative used as anaplastic lymphoma kinase (ALK) inhibitor
|
|
CN104983717A
|
|
Sodium prasterone sulfate sustained-release capsule and preparation method thereof
|
|
CN104849388A
|
|
Method for determining residual organic solvent content in arbidol hydrochloride crude drug
|
|
CN104860946A
|
|
Preparation method of CCR5 antagonist
|
|
WO2016090730A1
|
|
Method for determining content of impurities in lapatinib by using lc-ms/ms
|
